Home >Products> Other Lab Equipments >Radioactivity / Luminescence> Micro-quantity florescent detection instrument
Other Lab Equipments:  Drug Tests / Pharmaceutics   Environmental Monitors   Food & Beverage   Radioactivity / Luminescence   Miscellaneous  
Micro-quantity florescent detection instrument
Micro-quantity florescent detection instrument
Xi’an Tianlong Science and Technology
| |
  • Product Detail
    Micro-quantity florescent detection instrument TL998A

    The Fluorescence Detection System for end-point QPCR (FDS) provides an economical solution of end-point quantitative PCR detection after PCR cycling. The real-time quantitative PCR detection system is more expensive than the FDS plus the PCR cycler. The FDS can be connected with computers via RS232C serial interface. The powerful and easy-operating software supplies many functions such as data procession and analyzer, medical case statistic, database management and so on. Additional, customers can get remote guide and remote quantity-control through the Internet if they connect the FDS with computer.

    Key Features

    • End-point quantitative PCR detection.

    • Specially designed for PCR cycler.

    • Can be connected with computer via RS232C interface.

    • Powerful software, supply data procession and analysis, medical case statistic, database management.

    • Remote guide and remote quality-control enable.

    • Operating easy.

    High reliability and economy.



    FAM, FITC, SYBR. various fluorescence PCR reagents, such as TaqMan probe, etc.

    Sample volume

    20-100 μl

    Wavelength of exciting fluorescence

    470 nm

    Wavelength of fluorescence detection

    530 nm (changeable)

    Monochromator device

    Filter, made in USA

    Photo Detector

    PMT (Photomultipier tube), made in Japan

    Correlative coefficient

    R ≥ 0.96

    Test Precision

    0.1 RLU


    High-light LCD, 20 × 2 pixel

    Data communication interface

    Connected with computer via RS232C interface

    Light source


    Input power

    AC 220 ± 22 V , 50 ± 1 Hz


    60 W


    500 mm × 350 mm × 200 mm


    6 ㎏

    Operating environment

    Ambient Temperature 5 °C -40 °C

    Relative Humidity 30%-70%

    Since its establishment in 1997, Tianlong has been committed to the research and development, production and overall solutions of instruments and in vitro diagnostic reagents in the field of genetic testing and molecular diagnostics. With its own sustainable development and potential values, Tianlong has received investments from SK Group, the 57th largest company in the Fortune Global 500 list, and Kehua Bio-Engineering, a listed company in China, in 2012 and 2018.

    As a high-tech enterprise in China, Tianlong Technology is responsible for many major scientific research and industrialization projects such as the National Key Research and Development Program, the National Special Project for the Development of Major Scientific Instruments and Equipment, and the National Science and Technology Support Program. ISO9001-certified and 13485-standard, Tianlong now has hundreds of products such as nucleic acid extractor, automated nucleic acid workstation, gene amplification instruments, real-time PCR instruments, ATP fluorescence detector and supporting test reagents. over 50 products have been approved by NMPA with medical device registration certificates, and more than 20 products have been approved by EU (CE) and KFDA (South Korea).

    Tianlong products are widely applied in the fields of medical diagnosis, food safety, epidemic prevention and control, customs and quarantine, forensics, scientific research, etc., and have contributed to the prevention and control of various major epidemics such as avian flu, Ebola, MERS, African swine fever and neonatal pneumonia. At present, Tianlong is serving more than 2,000 customers in more than 40 countries and regions including, Korea, the United States, France, Germany, Denmark, the United Arab Emirates, Pakistan, and so on.

    At the end of 2019, after the outbreak of the epidemic, Tianlong quickly launched SARS-CoV-2 rapid nucleic acid detection solution, successively detected the first positive samples in many provinces in China, and made a great contribution to the epidemic prevention and control globally. Tianlong successively received letters of thanks from the State Council of China, the National Center for Disease Control of China, and the Slovakian government. Tianlong was then reported by CCTV News, Xinhua News Agency, People's Daily and other authoritative media.

    In the face of future opportunities and challenges, we will continue to create first-class molecular diagnostic products and work hard for human health in a more open way of cooperation with all walks of life.
Request Infomation
Request Infomation: yes no
Request Quotation: yes no

I agree to share my inquiry with the other matching suppliers.

Request Infomation

* Name:
Job Title:
* Tel:
* E-mail:
* Country:
Request Infomation:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
I agree to share my inquiry to the other matching suppliers.